Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Cord Blood Transplantation for Patients With Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treatment of Sickle Cell Anemia With Stem Cell Transplant
- Status
- TERMINATED
- Phase
- NA
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...
- Status
- COMPLETED
- Phase
- PHASE2
Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- N/A
A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
- Status
- TERMINATED
- Phase
- PHASE4
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Drosophila-generated CTL
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
- Status
- TERMINATED
- Phase
- PHASE4
A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2